Photo by @veradavidovaphotography Vera Davidova
“The article discusses infection risk for the hematological malignancies for all the illnesses listed in the first paragraph but, somewhat unfortunately, to a lesser extent for MM considering the very limited patient experiences with the anti-BCMA products. Still, a number of observations and conclusions are very relevant for us, myeloma patients.”…
A topical article over at Myeloma Crowd regarding Car T and elevated infection risk for patients. It’s worth a read, though the data is still coming in. In the meantime, as with all things Myeloma and Immunosuppressed related, take recommended precautions and a tad more!
Thank you Myeloma Crowd for always being on top of things! (Click the hyperlink in the copy to see the article.)
